Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry.

Medicina clinica - 1 Apr 2026

Ezquerra-Durán Alberto, Guillen-Del-Castillo Alfredo, Felix Tellez Francisco Alejandro, Argibay-Filgueira Ana, Marí-Alfonso Begoña, Freire Mayka, Alcalá-González Luis G, Simeón-Aznar Carmen P

Abstract excerpt

INTRODUCTION: Gastrointestinal (GI) involvement is the most frequent visceral manifestation of systemic sclerosis (SSc) and is associated with increased morbidity and mortality. To date, its characterization using specific diagnostic tests has been poorly described in the Spanish population. METHODS: A cross-sectional study was conducted including patients with SSc enrolled in the Spanish Multidisciplinary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antibodies, Antinuclear

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Gastrointestinal Diseases

Share to Prevalence

Share to Registries

Share to Scleroderma, Systemic

Source

Identifiers

PMID: 41812522
DOI: 10.1016/j.medcli.2026.107374

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry.PMID 41812522Read ↗

Proteome-wide serology reveals immune-defined subtypes of gastrointestinal disease in systemic sclerosisSemantic proximity Read ↗

Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis.Semantic proximity Read ↗

Novel autoantibodies in patients with systemic sclerosis and gastrointestinal dysfunction provide insight into disease pathogenesisSemantic proximity Read ↗

Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosisSemantic proximity Read ↗

The Gut-Heart Axis in Systemic Sclerosis: Evidence from the GENISOS cohortSemantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort.Semantic proximity Read ↗

The Evolving Landscape of Systemic Sclerosis Pathogenesis: From Foundational Mechanisms to Organ-Specific ModifiersSemantic proximity Read ↗

Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis.Semantic proximity Read ↗

Antivinculin Antibodies in Systemic Sclerosis: Associations With Slow Gastric Transit and Extraintestinal Clinical Phenotype.Semantic proximity Read ↗

Determining the Risk Factors and Clinical Features Associated With Severe Gastrointestinal Dysmotility in Systemic Sclerosis.Semantic proximity Read ↗

PPI-Refractory GERD in Systemic Sclerosis Is Driven by Distinct Esophageal and Gastric Motility AbnormalitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.